Canada was the third country that allowed the use of the vaccine produced by Kovid-19.
SE, before the US Food and Drug Administration and the European leader in approving regulatory agencies for its most vulnerable citizens.
Canada begins immunization as early as next week, which is a challenge for the world’s second largest but sparsely populated country. The country plans to begin immunization next week with a portfolio of candidate vaccines that it believes to be one of the most diverse among the major economies.
The F.D.A. should be able to launch the vaccine this weekend after its own study concluded that the two-dose vaccine offers benefits after the first injection and reduces the risk of contracting Covid-19 by about half. The vaccine was 95% effective after the second dose. The European Medicines Agency has announced that it has decided to discontinue Pfizer-BioNTech or
the vaccine could be here by the end of the month.
Last week, Canada, along with Great Britain and Bahrain, approved Pfizer’s BioNTech vaccine.
The Canadian regulatory authorities have published a notice of approval on the Internet. A Pfizer Canada spokesman said Wednesday that Pfizer will ship up to 76 million doses of the vaccine to Canada. The transaction includes a final agreement for Canada to purchase at least 20 million doses with an option for a further $56 million.
During the race of U.S. states and hospitals for the first Covid 19 vaccines, Daniela Hernandez heard the hospital administrator and vaccination specialist talk about the logistical challenges of this first phase of the vaccination process.
On Monday, Canada announced that it had secured an early delivery of 249,000 first doses and expected vaccinations to begin next week.
Prime Minister of Canada
told the Wall Street Journal on Monday that the license would be issued shortly. According to him, the planned introduction of the vaccine, together with an aggressive fiscal policy, will contribute to the economic recovery, which is expected to accelerate in mid-2021.
According to Trudeau, the goal is to have three million Canadians by the end of the first quarter and the majority of the 38 million by September.
To date, the Canadian immunization strategy has focused on collecting as many doses per capita as possible. Mr Trudeau and other officials boast that Canada is the world leader in this category. To date, Canada has reported that it has granted access to more than 400 million doses, but it has not disclosed the financial terms of the agreements with the seven main candidates.
Canada is committed to building the best and most diversified portfolio of potential vaccines in virtually every other country, Trudeau told this week’s Board Summit. With the start of population vaccination, hopefully next week… …we really will see the beginning of the end of the pandemic.
Canadian Prime Minister Justin Trudeau in Ottawa on Monday.
Canada exaggerates its success in accessing vaccines, said.
as a professor of the School of Epidemiology at the University of Ottawa.
The three million doses that Canada will receive at the end of March are only a fraction of the 50 million doses expected in the United States. It’s not very good, Mr. Attaran said. Even after adapting to the population he leaves Canada behind him, he said.
According to a virologist and honorary professor at the University of Ottawa, Canada has done an excellent job covering its databases of potential vaccines, as it is not clear which one is the most effective. You can’t criticize them in this case, he said. They don’t know which manufacturers will stumble and fall in the race.
For example, Canada has also contracted Moderna to purchase up to 56 million doses of the Covid-19 candidate vaccine, and regulators are awaiting a decision on the vaccine in the coming month. According to Trudeau, the country expects Moderna’s vaccine, if approved, to reach more isolated communities and northern Canadians because it is less difficult to transport than Pfizer’s vaccine.
Pfizer BioNTech vaccine is difficult to store and transport. It must be kept in a cool place for six months at a temperature between – 112 and – 76 degrees Fahrenheit. The vaccine remains viable for 120 hours under normal cooling. Canadian officials say they bought 126 freezers to store Covid-19 vaccines, including 26 for the ultra-low temperature needed for a Pfizer BioNTech injection.
Canadian public health officials have identified nursing home residents as the primary recipients of the Covida 19 vaccine. According to the National Institute on Ageing at Ryerson University, about three-quarters of the approximately 13,000 Covid-19 related deaths occurred in these institutions.
Canada’s Chief Medical Officer said there were problems because authorities could not easily move residents from a nursing home to one of Pfizer-BioNTech’s original 14 injection sites. I really believe this is an unstable situation, she said, and added that the authorities are working on a solution.
More information about the coronavirus pandemic
Copyright ©2020 Dow Jones & Company, Inc. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8